Is SoFi Stock a Buy After Q2 Earnings Beat?

: SOFI | SoFi Technologies Inc. News, Ratings, and Charts

SOFI – Digital financial services company SoFi technologies (SOFI) topped its second-quarter earnings estimates, which buoyed the stock. However, with its bottom line still in the red, would it be wise to invest in the stock now? Read on to find out….

SoFi Technologies, Inc. (SOFI) offers digital financial services and operates through the three broad segments of Lending; Technology Platform; and Financial Services. The company provides student loans, personal loans for debt consolidation and home improvement projects, and home loans.

SOFI announced a second-quarter total net revenue of $362.53 million, up 57% year-over-year, which buoyed its stock. This topped the $344 million consensus estimate. The company reported a net loss of $95.84 million or 12 cents a share on a GAAP basis, narrowing its losses. FactSet analysts were expecting a 14 cents loss per share for the quarter. The company’s net loss and loss per share were $165.31 million and $0.48 in the prior-year quarter.

Over the past year, SOFI’s stock has declined 56.1%. It has declined 53.1% year-to-date to close its last trading session at $7.42. However, the stock has been up 23.5% over the past month.

Here are the factors that could affect SOFI’s performance in the near term:

New Exchange-Traded Fund Launch

SOFI entered the cryptocurrency play through the launch of its fund, focusing on NFTs, blockchain technology, and the metaverse. The SoFi Web 3 ETF (TWEB) tracks the SoFi Solactive ARTIS Web 3.0 Index. The company launched the Web3 fund alongside a smart energy ETF, seeking to continue building its suite of thematic products.

Negative Profit Margins

SOFI’s trailing-12-month gross profit margin of 76.37% is 20.1% higher than the industry average of 63.57%. However, its trailing-12-month net income margin of a negative 28.46% is significantly lower than the industry average of 28.09%. Its ROE and ROA of a negative 8.25% and 2.74% compare to their respective industry averages of 11.60% and 1.20%.

Stretched Valuations

In terms of its forward Price/Sales, SOFI is trading at 4.80x, 62.6% higher than the industry average of 2.95x. The stock’s forward Price/Book multiple of 1.40 is 17% higher than the industry average of 1.20.

POWR Ratings Reflect A Bleak Outlook

SOFI’s POWR Ratings reflect this bleak outlook. The stock has an overall F rating, equating to a Strong Sell in our proprietary rating system. The POWR Ratings are calculated by considering 118 different factors, with each factor weighted to an optimal degree.

SOFI has a Quality grade of F in sync with its negative profitability margins. The stock also has a D grade for Value, consistent with its stretched valuations.

In the 108-stock Financial Services (Enterprise) industry, SOFI is ranked #107. The industry is rated F.

Click here to see the additional POWR Ratings for SOFI (Growth, Momentum, Stability, and Sentiment).

View all the top stocks in the Financial Services (Enterprise) industry here.

Bottom Line

SOFI’s recent crypto ETF launch might benefit the company. However, it seems we are in the middle of the crypto winter, and given the anticipated regulations in the crypto market, I think the stock might be best avoided now. Moreover, its bleak bottom line and negative ROE are concerning.

How Does SoFi Technologies, Inc. (SOFI) Stack Up Against its Peers?

While SOFI has an overall POWR Rating of F, one might consider looking at its industry peers, Forrester Research, Inc. (FORR), which has an overall A (Strong Buy) rating, and CPI Card Group Inc. (PMTS) and Everi Holdings Inc. (EVRI), which have an overall B (Buy) rating.


SOFI shares were trading at $7.55 per share on Friday morning, up $0.13 (+1.75%). Year-to-date, SOFI has declined -52.25%, versus a -10.43% rise in the benchmark S&P 500 index during the same period.


About the Author: Anushka Dutta


Anushka is an analyst whose interest in understanding the impact of broader economic changes on financial markets motivated her to pursue a career in investment research. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
SOFIGet RatingGet RatingGet Rating
FORRGet RatingGet RatingGet Rating
PMTSGet RatingGet RatingGet Rating
EVRIGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

2 Best Stocks of All Time!

This bear market has me thinking back to my 2 best trades of all time. That being when I bought Amazon (AMZN) and Booking (BKNG) back in 2001 as they were tumbling down in the midst of a bear market...but now enjoying truly phenomenal gains. Let’s discuss what those investments had in common and how that will help us find more big winners in the years ahead. Read on below for more...

:  |  News, Ratings, and Charts

Bears Back in Charge...What Happens Next?

A month ago the bulls were claiming victory as they created a charge back over 4,000 for the S&P 500 (SPY). Since then that false narrative has been peeled away and investors are more honestly looking at the bleak outlook formed by high inflation and a hawkish Fed. That explains why we are back retesting the June lows. Now we have to ponder what comes next and how to trade our way to profits. Read on below for the full story...

:  |  News, Ratings, and Charts

3 Healthcare Stocks Under $100 to Buy Right Now

The rising prevalence of chronic diseases and the aging population are major growth drivers for the healthcare industry. In addition, increased investments in technological advancements should further bolster the industry’s growth. Thus, we think it may be prudent to buy quality healthcare stocks Pfizer Inc. (PFE), Merck & Co. (MRK), and Bristol-Myers Squibb (BMY), which are currently trading under $100. Read on…

:  |  News, Ratings, and Charts

Cut These 2 Stocks From Your Portfolio Right Now

The Fed succeeding in a ‘soft landing’ seems unlikely. Analysts are expecting a recession soon. So, with the rising odds of the Fed raising rates aggressively, it could be wise to steer clear of fundamentally weak stocks Roblox (RBLX) and Affirm Holdings (AFRM). Read on…

:  |  News, Ratings, and Charts

3 Healthcare Stocks Under $100 to Buy Right Now

The rising prevalence of chronic diseases and the aging population are major growth drivers for the healthcare industry. In addition, increased investments in technological advancements should further bolster the industry’s growth. Thus, we think it may be prudent to buy quality healthcare stocks Pfizer Inc. (PFE), Merck & Co. (MRK), and Bristol-Myers Squibb (BMY), which are currently trading under $100. Read on…

Read More Stories

More SoFi Technologies Inc. (SOFI) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All SOFI News